BCX10013

· BioCryst Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BCX10013, covering 2025-01-08 to 2025-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation of BCX10013 in Participants with Paroxysmal Nocturnal Hemoglobinuria (PNH) [Phase 1]